Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Director sold 2,000 shares at $14.68 ($29,360)
  6. 4 Open-market sale Chief Executive Officer sold 162,500 shares at an average $14.71 ($2,390,000)
  7. 4 Open-market sale Chief Operating Officer sold 28,336 shares at an average $15.05 ($426,383)
  8. 4 Open-market sale Chief Operating Officer sold 45,049 shares at an average $12.03 ($541,719)
  9. 4 Open-market sale CFO sold 30,000 shares at $10.02 ($300,558)
  10. 4 Option exercise Director acquired 4,274 shares (option exercise)
  11. 4 Open-market sale Director sold 961 shares at $9.48 ($9,110)
  12. 4 Open-market sale Director sold 2,750 shares at $9.00 ($24,750)
  13. 4 Gift Chief Executive Officer gave 10,000 shares (gift)
  14. 4 Open-market sale CFO sold 20,000 shares at $10.69 ($213,706)
  15. 4 Open-market sale Director sold 17,500 shares at $10.71 ($187,352)
  16. 4 Option exercise Director acquired 4,090 shares (option exercise)
  17. 4 Open-market sale Chief Scientific Officer sold 19,466 shares at $9.75 ($189,794)
  18. 4 Open-market sale Chief Scientific Officer sold 19,467 shares at $19.06 ($371,004)
  19. 4 Open-market sale Chief Executive Officer sold 100,000 shares at $21.13 ($2,113,450)
  20. 4 Open-market sale CFO sold 35,000 shares at $24.95 ($873,208)

Page 9 of 30 · 592 filings